5431 - 5440 of 9038 Results
Title
Year
- The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements2016RESTRICTEDTitle: The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurementsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 105Issue #:Start Page: 651End Page: 660Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.01.013Citation Count: 39
- Progressive supranuclear palsy against everyone else: a look into the specificity of MRI markers2025OPENTitle: Progressive supranuclear palsy against everyone else: a look into the specificity of MRI markersJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 478Issue #:Start Page: 123731End Page: 123731Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2025.123731Best OA location URL: https://doi.org/10.1016/j.jns.2025.123731Citation Count: 1
-
OPENTitle: Distinct Roles of the Human Subthalamic Nucleus and Dorsal Pallidum in Parkinson’s Disease ImpulsivityJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 91Issue #: 4Start Page: 370End Page: 379Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2021.03.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8419208Citation Count: 13
- Disease-modifying therapies for Parkinson's disease2013OPENTitle: Disease-modifying therapies for Parkinson's diseaseJournal Name: The Biomedical & Life Sciences CollectionPublisher: Henry Stewart TalksVol: 2013Issue #: 3Start Page: e1003178End Page: e1003178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.69645/krxj9755Citation Count: 0
- Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMI2026RESTRICTEDTitle: Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMIJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78230Citation Count: 0
- Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)2019RESTRICTEDTitle: Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p5.8-050Citation Count: 0
-
OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol: 35Issue #: 5Start Page: 981End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://doi.org/10.1080/10543406.2023.2170400Citation Count: 8
- Changes in neuronal activity of cortico‐basal ganglia–thalamic networks induced by acute dopaminergic manipulations in rats2017RESTRICTEDTitle: Changes in neuronal activity of cortico‐basal ganglia–thalamic networks induced by acute dopaminergic manipulations in ratsJournal Name: European Journal of NeurosciencePublisher: WileyVol: 47Issue #: 3Start Page: 236End Page: 250Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.13805Citation Count: 11
-
OPENTitle: MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320aJournal Name: Journal of NeuroimmunologyPublisher: Elsevier BVVol: 278Issue #:Start Page: 185End Page: 189Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jneuroim.2014.11.004Best OA location URL: http://doi.org/10.1016/j.jneuroim.2014.11.004Citation Count: 64
-
OPENTitle: Nanorod-associated plasmonic circular dichroism monitors the handedness and composition of α-synuclein fibrils from Parkinson's disease models and post-mortem brainJournal Name: NanoscalePublisher: Royal Society of Chemistry (RSC)Vol: 16Issue #: 40Start Page: 18882End Page: 18898Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d4nr03002hBest OA location URL: http://dx.doi.org/10.1039/d4nr03002hCitation Count: 0